MONISTAT 7 DUAL-PAK 100 MG
MICONAZOLE NITRATE : 100 MG MICONAZOLE NITRATE : 2 % · DIN 02126257 · INSIGHT PHARMACEUTICALS, LLC
Health Canada status: MARKETED
What is MONISTAT 7 DUAL-PAK?
MONISTAT 7 DUAL-PAK 100 MG contains MICONAZOLE NITRATE : 100 MG MICONAZOLE NITRATE : 2 %. It is listed in the Health Canada Drug Product Database under DIN 02126257, held by INSIGHT PHARMACEUTICALS, LLC, supplied as CREAM ; SUPPOSITORY for TOPICAL ; VAGINAL administration. Health Canada currently lists it as marketed, status dated 11-Dec-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MONISTAT 7 DUAL-PAK used for?
Local treatment of vulvovaginal candidiasis (moniliasis) and relief of associated external itching and irritation.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02126257 |
|---|---|
| Brand name | MONISTAT 7 DUAL-PAK |
| Generic / active ingredient | MICONAZOLE NITRATE : 100 MG MICONAZOLE NITRATE : 2 % |
| Manufacturer | INSIGHT PHARMACEUTICALS, LLC |
| Strength | 100 MG |
| Dosage form | CREAM ; SUPPOSITORY |
| Route of administration | TOPICAL ; VAGINAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | G01AF04 MICONAZOLE |
| AHFS class | 84:04.08.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 11-Dec-2012 |
| Original market date | 1994-12-31 00:00:00 |
How is it administered?
Cream: 5g daily for 7 days. Ovule: 400mg daily for 3 days. Dual-Paks: Intravaginal treatment plus external cream applied twice daily for up to 7 days. Administer at bedtime.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at controlled room temperature (15°C - 30°C).
How is it supplied?
Cream: 7 prefilled applicators. Ovules: 3 ovules with applicators. Dual-Paks: Suppositories (7) or Ovules (3) plus a 9g tube of 2% cream.
Contraindications
Known hypersensitivity to this drug or any of its ingredients.
Warnings and precautions
Discontinue if sensitization/irritation occurs. Reduces effectiveness of latex condoms/diaphragms. Consult doctor if first-time infection, fever, or abdominal pain occurs.
What can be used instead?
Other Canadian products sharing ATC code G01AF04 MICONAZOLE. 6 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MICONAZOLE 3 DAY OVULE TREATMENT 400MG | 400 MG | SUPPOSITORY | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02171775 |
| MICONAZOLE NITRATE VAGINAL CREAM 2% | 2 % | CREAM | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02245546 |
| MICONAZOLE NITRATE VAGINAL CREAM USP, 2% | 2 % | CREAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 02231533 |
| MONISTAT 3 VAGINAL CREAM | 4 % | CREAM | INSIGHT PHARMACEUTICALS, LLC | MARKETED | DIN 02244005 |
| MONISTAT 7 VAGINAL CREAM | 2 % | CREAM | INSIGHT PHARMACEUTICALS, LLC | MARKETED | DIN 02084309 |
| MICONAZOLE 7 - CRM VAG 2% | 2 % | CREAM | TECHNILAB PHARMA INC. | CANCELLED POST MARKET | DIN 02194368 |
| MICOZOLE | 2 % | CREAM | TARO PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02231106 |
| MONAZOLE 7 - CRM 20MG/G | 20 MG | CREAM | TECHNILAB PHARMA INC. | CANCELLED POST MARKET | DIN 02219476 |
| MONISTAT 1 COMBINATION PACK | 2 % | CREAM ; SUPPOSITORY | INSIGHT PHARMACEUTICALS, LLC | DORMANT | DIN 02239600 |
| MONISTAT 1 VAGINAL OVULE | 1200 MG | SUPPOSITORY | INSIGHT PHARMACEUTICALS, LLC | DORMANT | DIN 02239601 |
Who else supplies MICONAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MICONAZOLE appears in 785 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.